GlassScriptPhysician profile
Joseph Pugh
NPI 1275605834
$1,427.56
in general payments reported to CMS, 2019-2025
25 companies · $471 in 2025
The $471 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $302 · 2020: $49.13 · 2024: $606 · 2025: $471.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,077.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,076.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo USA, INC. | $236.39 | 2024-2025 | Xiaflex, Aveed |
| Procept Biorobotics Corporation | $143.48 | 2019-2025 | |
| Abc Home Medical Supply, INC. | $118.56 | 2024-2025 | |
| Medtronic, INC. | $113.99 | 2024-2025 | Interstim |
| Ipsen Biopharmaceuticals, INC | $83.40 | 2019-2020 | |
| Astellas Pharma US INC | $78.43 | 2019 | |
| Sumitomo Pharma America, INC. | $66.59 | 2024 | Orgovyx |
| Genzyme Corporation | $63.93 | 2019 | |
| Olympus America INC. | $53.06 | 2024 | Itind System |
| Teleflex LLC | $48.66 | 2024-2025 | Urolift, Barrigel |
| Smith+Nephew, INC. | $46.76 | 2024 | Bone Anchors With Arthroscopic Delivery System, Lens 4k, N/A |
| Endo Pharmaceuticals INC. | $43.66 | 2019-2024 | Xiaflex, Aveed |
| 180 Medical, INC. | $42.45 | 2024 | |
| Urogen Pharma, INC. | $39.43 | 2025 | |
| Dendreon Pharmaceuticals LLC | $33.70 | 2024 | Provenge |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Laborie Medical Technologies Corp. | $28.02 | 2025 | |
| Abbvie INC. | $27.86 | 2025 | |
| Coloplast Corp | $25.00 | 2024 | |
| Glaukos Corporation | $24.69 | 2025 | Idosetr |
| Celgene Corporation | $24.64 | 2020 | |
| Boston Scientific Corporation | $23.77 | 2019 | |
| Photocure INC | $17.46 | 2024 | Cysview |
| Merck Sharp & Dohme LLC | $16.81 | 2019 | |
| Cgg Medical INC | $13.66 | 2024 | |
| Janssen Biotech, INC. | $13.16 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Pugh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.